Effectiveness of Artificial IntelliGence-Driven Single-LEad Long-TerM Electrocardiograms MonItoring in Detecting New-Diagnosed Atrial FIbrillation
A trial with no phase registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 15360 participants.
Also called NCT06842147
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose screening
- Phase
- Not applicable
- Enrolled
- 15,360 participants
- Sponsor
- Registry
-
NCT06842147
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- China
- Registry status
- Recruiting
Technical summary
Registry record NCT06842147. Randomized; no masking; primary purpose screening. Start 2025-03-01 (actual); primary completion 2028-07-30 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Effectiveness of Artificial IntelliGence-Driven Single-LEad Long-TerM Electrocardiograms MonItoring in Detecting New-Diagnosed Atrial FIbrillation
- Acronym
- GEMINI
- Condition
- Atrial Fibrillation (AF)
- Intervention (Device)
- 7-day single-lead long-term ECG (electrocardiogram) monitoring device.
- Intervention (Device)
- Standard Screening Group
- Lead sponsor
- Beijing Anzhen Hospital
Record details
- Record id
cardio:ct-nct06842147- Content hash
3abdee21da72375d9a3032a78ba143c2f3b6ddfbf7505de8e17bbfd45c4acf08